Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,987 | 102 | 99.7% |
| Education | $6.71 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $428.04 | 22 | $0 (2024) |
| Amgen Inc. | $409.90 | 18 | $0 (2024) |
| Lilly USA, LLC | $327.70 | 18 | $0 (2024) |
| Novo Nordisk Inc | $177.85 | 10 | $0 (2024) |
| ABBVIE INC. | $104.33 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $97.05 | 6 | $0 (2023) |
| Radius Health, Inc. | $66.42 | 4 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $61.67 | 4 | $0 (2022) |
| SANOFI PASTEUR INC. | $60.00 | 2 | $0 (2024) |
| Organon LLC | $50.95 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $615.99 | 30 | AstraZeneca Pharmaceuticals LP ($215.74) |
| 2023 | $405.15 | 24 | Lilly USA, LLC ($146.02) |
| 2022 | $702.05 | 32 | Amgen Inc. ($209.99) |
| 2021 | $270.68 | 17 | Amgen Inc. ($85.32) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Vaccines | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Bone Health | ||||||
| 07/23/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Oncology | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Respiratory | ||||||
| 04/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Respiratory | ||||||
| 04/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 43 | 73 | $16,846 | $4,291 |
| 2022 | 1 | 26 | 59 | $14,363 | $3,364 |
| 2021 | 3 | 71 | 130 | $21,740 | $6,003 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 52 | $13,088 | $3,294 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 21 | $3,758 | $996.54 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 59 | $14,363 | $3,364 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 59 | $14,219 | $4,110 | 28.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 36 | $6,156 | $1,788 | 29.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 23 | 35 | $1,365 | $105.00 | 7.7% |
About Helena Longfellow, APRN, FNP-C
Helena Longfellow, APRN, FNP-C is a Family healthcare provider based in Mahomet, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2020. The National Provider Identifier (NPI) number assigned to this provider is 1275131203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Helena Longfellow, APRN, FNP-C has received a total of $1,994 in payments from pharmaceutical and medical device companies, with $615.99 received in 2024. These payments were reported across 103 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,987).
As a Medicare-enrolled provider, Longfellow has provided services to 140 Medicare beneficiaries, totaling 262 services with total Medicare billing of $13,659. Data is available for 3 years (2021–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Mahomet, IL
- Active Since 10/12/2020
- Last Updated 02/27/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275131203
Products in Payments
- EVENITY (Biological) $256.43
- AIRSUPRA (Drug) $181.77
- JARDIANCE (Drug) $174.00
- FARXIGA (Drug) $171.10
- MOUNJARO (Drug) $155.70
- Ozempic (Drug) $141.30
- BREZTRI (Drug) $75.17
- VRAYLAR (Drug) $62.48
- ZENPEP (Drug) $61.67
- ENTRESTO (Drug) $61.50
- Tymlos (Drug) $43.86
- Rybelsus (Drug) $36.55
- LEQVIO (Drug) $35.55
- VAXELIS (Biological) $32.23
- WATCHMAN Access System (Device) $31.38
- NEXPLANON (Drug) $30.57
- Otezla (Drug) $28.47
- TRULICITY (Drug) $28.36
- BEYFORTUS (Biological) $27.77
- QULIPTA (Drug) $22.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.